UAE Patient at Home Testing Kits Market to grow with a CAGR of 6.15%
Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Patient at Home Testing Kits Market.
According to TechSci Research report, “UAE
Patient at Home Testing Kits
Market Industry Size, Share,
Trends, Competition, Opportunity and Forecast, 2018-2028”, UAE Patient at Home Testing Kits Market
has valued at USD 0.15 billion in 2022 and is anticipated to witness an
impressive growth in the forecast period with a CAGR of 6.15% through 2028.
This can be due to collaborations
and partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market.
The COVID-19 pandemic has had a
significant impact on driving the demand for Patient at Home Testing Kits in
the UAE. At-home testing kits became crucial during the COVID-19 pandemic for
individuals who wanted to test for the virus without going to a healthcare
facility. These kits allowed for convenient and non-invasive sample collection
at home, minimizing the risk of exposure. Public health guidelines and social
distancing measures during the pandemic encouraged individuals to seek
alternatives to traditional healthcare settings. At-home testing provides a
safe and convenient option for individuals to monitor their health without the
need for in-person visits. At-home testing kits increased accessibility to
COVID-19 testing, particularly for individuals who may be in remote areas or
unable to visit testing centers easily. This accessibility contributed to
widespread testing efforts, aiding in the early detection and containment of
the virus.
At-home testing helped alleviate the
pressure on healthcare facilities by allowing individuals with mild symptoms or
those seeking routine testing to do so at home. This reduced the burden on
testing centers and hospitals, enabling them to focus on more severe cases.
Individuals in quarantine or
isolation due to COVID-19 could use at-home testing kits to monitor their
symptoms and assess their recovery progress without leaving their homes. This
self-monitoring capability was particularly valuable during periods of
lockdown.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Patient at Home Testing Kits Market.”
In April 2020, The
National Home Testing Program for People of Determination has been announced by
the Crown Prince of Abu Dhabi, Sheikh Mohammed Bin Zayed Al Nahyan. Emphasizing
the importance of accessible testing for all segments of society, he
highlighted the success of the UAE in collecting test samples from over 500,000
individuals in recent weeks. The introduction of mobile Coronavirus testing
facilities has significantly enhanced the capacity to process patients beyond
conventional levels. The effective response from authorities has positioned the
UAE as the safest place globally from the Coronavirus. Ongoing efforts to
increase safety measures and the preparedness of healthcare facilities
underscore the commitment to addressing any unfortunate cases of infection.
Cultural
and societal factor present challenges in the UAE Patient at Home Testing Kits
Market. These factors influence how individuals perceive and adopt healthcare
practices, including the use of at-home testing kits. Cultural
beliefs and practices related to healthcare may influence individuals'
willingness to use at-home testing kits. Some cultural perspectives may
prioritize traditional healthcare practices or require the involvement of
healthcare professionals for testing. Cultural attitudes toward technology,
including healthcare technology, can impact the acceptance of at-home testing
kits. Individuals may be willing to use these kits based on their trust in
technology and perceptions of its reliability. Societal norms and concerns
about privacy may affect the adoption of at-home testing kits. In cultures
where health information is considered highly private, individuals may be
hesitant to use testing kits that involve self-collection of sensitive data.
UAE Patient at Home Testing
Kits Market is segmented based on Test Type, Sample, Usage, Distribution
Channel, and by region.
Based on the Test Type, UAE
Patient at Home Testing
Kits Market is segmented into Blood Glucose Testing, Pregnancy & Fertility
Testing, Cholesterol Testing, COVID-19 Testing, Urine Testing, and Others.
Cholesterol testing is a diagnostic procedure that measures the levels of
cholesterol and other lipids in the blood. Cholesterol is a fatty substance
that is essential for building cells and producing certain hormones. However,
elevated levels of cholesterol in the blood can be a risk factor for
cardiovascular diseases, including heart attacks and strokes. Cholesterol
testing is crucial for assessing an individual's risk of cardiovascular issues
and for guiding preventive measures and treatments. A blood sample is
usually taken from a vein in the arm. The sample is then analyzed to measure
the levels of total cholesterol, LDL cholesterol, HDL cholesterol, and
triglycerides. For
more accurate results, individuals may be required to fast for 9-12 hours
before the blood test. This helps measure lipid levels in a fasting state,
providing a more comprehensive assessment.
Based on Region, Abu Dhabi region held the largest share
in the UAE Patient
at Home Testing Kits Market.
Collaborations between healthcare
providers, technology companies, and government bodies can play a role in
promoting at-home testing. If there are strategic partnerships in Abu Dhabi
supporting the use of these kits, it could contribute to market dominance.
Cultural attitudes towards healthcare practices can influence the adoption of
at-home testing. If there is a cultural inclination in Abu Dhabi towards
proactive health monitoring, it could contribute to the dominance of at-home
testing in the market. Abu Dhabi has been an early adopter of healthcare
innovations, including at-home testing, it could have gained a significant
foothold in the market. Early adoption often leads to a more established
presence.
Some of the major companies operating in
the UAE Patient
at Home Testing Kits Market include:
- Abbott
Laboratories, SA (UAE)
- Roche
Diagnostics Middle East FZCO
- Siemens
Healthineers UAE
- Quidel
Corporation
- GE
Healthcare UAE
- Procter
& Gamble Middle East FZE
- Swiss
Precision Diagnostics GmbH (Clearblue)
- First
Response
Download free Sample Report
Customers
can also request 10% free customization on this report.
“Certain areas,
particularly in Dubai, are projected to exert significant demand for Home
Testing Kits. The growth in the competitive landscape and the presence of
well-established companies in the market, committed to enhance the overall
wellbeing of people each year, are expected to contribute to a remarkable
growth of the UAE Patient at Home Testing Kits Market in
the forecast period," said Mr. Karan Chechi, Research Director with
TechSci Research, a research-based Global management consulting firm.
UAE Patient at Home Testing
Kits Market by Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing,
Cholesterol Testing, COVID-19 Testing, Urine Testing, Others), By Sample
(Blood, Urine, Saliva/Swab, Others), By Usage (Reusable, Disposable), By
Distribution Channel (Retail Pharmacy Stores, Hypermarket/Supermarket,
E-Commerce), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE
Patient at Home Testing Kits Market and provides statistics & information
on market size, structure, and future market growth. The report intends to
provide innovative market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in UAE
Patient at Home Testing Kits Market.
Contact
Mr. Ken
Mathews
Techsci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
M:
+13322586602
Email: [email protected]
Website: https://www.techsciresearch.com